Click on each section you wish to purchase
Click on add to cart to add all the sections in shopping cart
Click on the cart to proceed to payment
Click on Checkout to complete the final checkout
Executive Summary
Acute Sensorineural Hearing Loss Global Clinical Trials Review, H2, 2018
Summary
GlobalData's clinical trial report, Acute Sensorineural Hearing Loss Global Clinical Trials Review, H2, 2018" provides an overview of Acute Sensorineural Hearing Loss clinical trials scenario. This report provides top line data relating to the clinical trials on Acute Sensorineural Hearing Loss. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database-Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.
The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Reasons to buy
- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
GlobalData Clinical Trials Report Coverage 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Countries Contributing to Clinical Trials in Middle East and Africa 14
Clinical Trials by G7 Countries: Proportion of Acute Sensorineural Hearing Loss to Ear Nose Throat Disorders Clinical Trials 15
Clinical Trials by Phase in G7 Countries 17
Clinical Trials in G7 Countries by Trial Status 18
Clinical Trials by E7 Countries: Proportion of Acute Sensorineural Hearing Loss to Ear Nose Throat Disorders Clinical Trials 19
Clinical Trials by Phase in E7 Countries 21
Clinical Trials in E7 Countries by Trial Status 22
Clinical Trials by Phase 23
In Progress Trials by Phase 24
Clinical Trials by Trial Status 25
Clinical Trials by End Point Status 27
Subjects Recruited Over a Period of Time 28
Clinical Trials by Sponsor Type 29
Prominent Sponsors 30
Top Companies Participating in Acute Sensorineural Hearing Loss Therapeutics Clinical Trials 32
Prominent Drugs 34
Clinical Trial Profile Snapshots 35
Appendix 61
Abbreviations 61
Definitions 61
Research Methodology 62
Secondary Research 62
About GlobalData 62
Contact Us 63
Source 63
List of Figures
Acute Sensorineural Hearing Loss Therapeutics, Global, Clinical Trials by Region (%), 2018* 7
Acute Sensorineural Hearing Loss Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 8
Acute Sensorineural Hearing Loss Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 10
Acute Sensorineural Hearing Loss Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2018* 11
Acute Sensorineural Hearing Loss Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2018* 12
Acute Sensorineural Hearing Loss Therapeutics Clinical Trials, North America, Top Countries (%), 2018* 13
Acute Sensorineural Hearing Loss Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2018* 14
Proportion of Acute Sensorineural Hearing Loss to Ear Nose Throat Disorders Clinical Trials, G7 Countries (%), 2018* 15
Acute Sensorineural Hearing Loss Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 17
Acute Sensorineural Hearing Loss Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 18
Proportion of Acute Sensorineural Hearing Loss to Ear Nose Throat Disorders Clinical Trials, E7 Countries (%), 2018* 19
Acute Sensorineural Hearing Loss Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 21
Acute Sensorineural Hearing Loss Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 22
Acute Sensorineural Hearing Loss Therapeutics, Global, Clinical Trials by Phase (%), 2018* 23
Acute Sensorineural Hearing Loss Therapeutics, Global, Clinical Trials In Progress by Phase, 2018* 24
Acute Sensorineural Hearing Loss Therapeutics, Global, Clinical Trials by Trial Status, 2018* 25
Acute Sensorineural Hearing Loss Therapeutics Clinical Trials, Global, by End Point Status, 2018* 27
Acute Sensorineural Hearing Loss Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 28
Acute Sensorineural Hearing Loss Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2018* 29
Acute Sensorineural Hearing Loss Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 30
Acute Sensorineural Hearing Loss Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 32
Acute Sensorineural Hearing Loss Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 34
GlobalData Methodology 62
List of Tables
Acute Sensorineural Hearing Loss Therapeutics, Global, Clinical Trials by Region, 2018* 7
Acute Sensorineural Hearing Loss Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 9
Acute Sensorineural Hearing Loss Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 10
Acute Sensorineural Hearing Loss Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2018* 11
Acute Sensorineural Hearing Loss Therapeutics Clinical Trials, Europe, Top Five Countries, 2018* 12
Acute Sensorineural Hearing Loss Therapeutics Clinical Trials, North America, Top Countries, 2018* 13
Acute Sensorineural Hearing Loss Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2018* 14
Proportion of Acute Sensorineural Hearing Loss to Ear Nose Throat Disorders Clinical Trials, G7 Countries (%), 2018* 16
Acute Sensorineural Hearing Loss Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 17
Acute Sensorineural Hearing Loss Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 18
Proportion of Acute Sensorineural Hearing Loss to Ear Nose Throat Disorders Clinical Trials, E7 Countries (%), 2018* 20
Acute Sensorineural Hearing Loss Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 21
Acute Sensorineural Hearing Loss Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 22
Acute Sensorineural Hearing Loss Therapeutics, Global, Clinical Trials by Phase, 2018* 23
Acute Sensorineural Hearing Loss Therapeutics, Global, Clinical Trials In Progress by Phase 2018* 24
Acute Sensorineural Hearing Loss Therapeutics, Global, Clinical Trials by Trial Status, 2018* 26
Acute Sensorineural Hearing Loss Therapeutics Clinical Trials, Global, by End Point Status, 2018* 27
Acute Sensorineural Hearing Loss Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 28
Acute Sensorineural Hearing Loss Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2018* 29
Acute Sensorineural Hearing Loss Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 31
Acute Sensorineural Hearing Loss Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 33
Acute Sensorineural Hearing Loss Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 34
Single User License:
Report can be used by individual purchaser only
Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office
Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company
Auris Medical Holding AG
Sensorion SA
Otologic Pharmaceutics Inc
Fonds NutsOhra
Lambda Therapeutic Research Ltd
Abbott Laboratories
Dermapharm AG
Cochlear Ltd
ClinSupport GmbH
CBR Systems Inc
Acute Sensorineural Hearing Loss Clinical Trials, Phase, Completed, Ongoing, Planned, End Points, Trial Locations, Trial Designs, Subjects Recruited, Safety, Efficacy, Bioequivalence, Pharmacokinetics, Pharmacodynamic, Sponsor, Collaborator, CRO's, Terminated, Suspended and Withdrawn trials of Acute Sensorineural Hearing Loss, Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas M. D. Anderson Cancer Center, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, University of Pennsylvania
For Regular updates on our latest research reports
Compare
|
|
| Details | |
| Date | |
| January 1970 | January 1970 |
| Pages | |
| Price | |
| USD | USD |
| Companies Covered | |
| Products | |
| Publisher | |
| Discount Offer | |
| - | - |
| Download TOC | Scope | LOF | LOT | |
 |
|
| 
